He, Xiaolong https://orcid.org/0000-0002-1509-8739
Hu, Mengyao https://orcid.org/0000-0002-0326-2781
Xu, Yi https://orcid.org/0000-0003-4316-5297
Xia, Fangbo
Tan, Yang
Wang, Yuqing https://orcid.org/0000-0002-8941-4095
Xiang, Huiling
Wu, Hao
Ji, Tengfei
Xu, Qian
Wang, Lei
Huang, Zhenhe
Sun, Meiling
Wan, Yu
Cui, Peng
Liang, Shaocong
Pan, Yuan
Xiao, Siyu
He, Yan
Song, Ruixin
Yan, Junqing
Quan, Xin
Wei, Yingge
Hong, Changze
Liao, Weizuo
Li, Fuli
El-Omar, Emad https://orcid.org/0000-0002-0011-3924
Chen, Jinjun https://orcid.org/0000-0003-4275-9149
Qi, Xiaolong https://orcid.org/0000-0002-3559-5855
Gao, Jie https://orcid.org/0000-0001-9180-2276
Zhou, Hongwei https://orcid.org/0000-0003-2472-8541
Article History
Received: 19 February 2024
Accepted: 7 November 2024
First Online: 8 January 2025
Competing interests
: J.G., X.H. and H.Z. are listed as inventors on two patents concerning the use of R. gnavus as a therapeutic or diagnostic target for hepatic encephalopathy.